Cytokine and chemokine patterns across 100days after hematopoietic stem cell transplantation in children

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 3, 2014, Pages 361-369

  DiCarlo, Joseph ^a   Agarwal Hashmi, Rajni ^b   Shah, Ami ^c   Kim, Paul ^d   Craveiro, Laila ^b   Killen, Renna ^a   Rosenberg Hasson, Yael ^b   Maecker, Holden ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Cytokines; Graft versus host disease; Hepatocyte growth factor; Veno occlusive disease

Indexed keywords

CD40 ANTIGEN; CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; NERVE GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; SCHOOL CHILD; VEIN OCCLUSION;

BONE MARROW TRANSPLANTATION; CYTOKINES; GRAFT-VERSUS-HOST DISEASE; HEPATOCYTE GROWTH FACTOR; VENO-OCCLUSIVE DISEASE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFANT; INFANT, NEWBORN; LIVER; MALE; PROSPECTIVE STUDIES; RESISTIN; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84896805953     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.11.026     Document Type: Article

References (24)

1. McDonald G.B., Sharma P., Matthews D.E., et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984, 4:116-122.
2. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
3. Luminex Corporation. xPonent® logistic curve fitting: technical notes. Available at:. Accessed January 10,2012. http://www.luminexcorp.com/prod/groups/public/documents/lmnxcorp/207-xponent3.1-log-curve-fit.pdf.
4. Linkov F., Gu Y., Arslan A.A., et al. Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw 2009, 20:21-26.
5. Hofmann J.N., Yu K., Bagni R.K., et al. Intra-individual variability over time in serum cytokine levels among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cytokine 2011, 56:145-148.
6. Clendenen T.V., Lundin E., Zeleniuch-Jacquotte A., et al. Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011, 20:799-810.
7. Pappa C.A., Tsirakis G., Kanellou P., et al. Monitoring serum levels ELR(+) CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma. Cytokine 2011, 56:616-620.
8. Manoura A., Gourgiotis D., Galanakis E., et al. Circulating concentrations of α- and β-chemokines in neonatal sepsis. Int J Infect Dis 2010, 14:e806-e809.
9. Suzuki K., Matsuzaki H., Iwata K., et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6:e20470.
10. Ormstad H., Aass H.C., Lund-Sørensen N., et al. Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. JNeurol 2011, 258:677-685.
11. Kornacker M., Roth A., Christensen O., et al. Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers-comparison of ELISA and microsphere-based multiplexed immunoassay. Clin Chem Lab Med 2008, 46:1256-1264.
12. Codorean E., Nichita C., Albulescu L., et al. Correlation of XMAP and ELISAcytokine profiles: development and validation for immunotoxicological studies invitro. Roum Arch Microbiol Immunol 2010, 69:13-19.
13. Loo B.M., Marniemi J., Jula A. Evaluation of multiplex immunoassays, used for determination of adiponectin, resistin, leptin, and ghrelin from human blood samples, in comparison to ELISA assays. Scand J Clin Lab Invest 2011, 71:221-226.
14. Panoskaltsis-Mortari A., Griese M., Madtes D.K., et al. American ThoracicSociety Committee on Idiopathic Pneumonia Syndrome. Anofficial American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 2011, 183:1262-1279.
15. Jang J.-E., Hod E.A., Spitalnik S.L., Frenette P.S. CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions. JClin Invest 2011, 121:1397-1401.
16. Michalopoulos G.K., Zarnegar R. Hepatocyte growth factor. Hepatology 1992, 15:149-154.
17. Richardson P., Guinan E. Hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Acta Haematol 2001, 106:57-68.
18. Gugliotta L., Catani L., Vianelli N., et al. High plasma levels of tumor necrosis factor-α may be predictive of veno-occlusive disease in bone marrow transplantation. Blood 1994, 83:2385-2386.
19. Holler E., Kolb H.J., Möller A., et al. Increased serum levels of tumor necrosis factor-α precede major complications of bone marrow transplantation. Blood 1990, 75:1011-1016.
20. Schots R., Kaufman L., Van Riet I., et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003, 17:1150-1156.
21. Cutler C., Kim H.T., Ayanian S., et al. Prediction of veno-occlusive disease using biomarkers of endothelial injury. Biol Blood Marrow Transplant 2010, 16:1180-1185.
22. Pihusch V., Pihusch M., Penovici M., et al. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation. Thromb Res 2005, 116:233-240.
23. Harris A.C., Ferrara J.L., Braun T.M., et al. Plasma biomarkers of lower gastrointestinal and liver acute graft-versus-host disease. Blood 2012, 119:2960-2963.
24. Paczesny S., Krijanovski O.I., Braun T.M., et al. Abiomarker panel for acute graft-versus-host disease. Blood 2009, 113:273-278.